Capital Equity Review

ChemoCentryx Inc (NASDAQ:CCXI) Grants Marketing Rights for CCX168 for $25M Investment

Cytori Therapeutics Inc (NASDAQ:CYTX) Gets EC Orphan Drug Status for Cell...

Nutech Energy Resources Inc (OTCMKTS:NERG) Receives Buyout Offer

Why Crocs, Inc. (NASDAQ:CROX) Shares Are Up More Than 30%

Time to Hop in the Argos Therapeutics Inc (NASDAQ:ARGS) Stock Rally?

Depomed Inc (NASDAQ:DEPO) Rallies 15% on Analysts’ Upgrades